
COPD Cases and Conversations
A Focus on Exacerbation Prevention
Meeting Slides

Guidelines
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.
Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2020 report.
Pharmacologic Management of Chronic Obstructive Pulmonary Disease: An Official American Thoracic Society Clinical Practice Guideline.
Nici L, et al. Am J Respir Crit Care Med. 2020; 201(9):e56–e69.
Clinical Management of COVID19, Interim Guidance.
World Health Organization, May 2020.
Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
Wedzicha JA, et al. Eur Respir J. 2017;50(3):1602265.
Suggested Readings
GOLD COVID19 Guidance.
Global Initiative for Chronic Obstructive Lung Disease (GOLD).
Reducing chronic obstructive pulmonary disease hospital readmissions. An official American Thoracic Society workshop report.
Press VG, et al. Ann Am Thorac Soc. 2019;16(2):161-170.
Predicting acute exacerbations in chronic obstructive pulmonary disease.
Samp JC, et al. J Manag Care Spec Pharm. 2018;24(3):265–279.
Triple versus dual inhaler therapy in moderate‐to‐severe COPD: a systematic review and meta‐analysis of randomized controlled trials.
Zayed Y, et al. Clin Respir J. 2019;13(7):413-428.
Once-daily single-inhaler triple versus dual therapy in patients with COPD.
Lipson DA, et al. N Engl J Med. 2018; 378(18):1671-1680.
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicenter, phase 3 randomised controlled trial.
Ferguson GT, et al. Lancet Respir Med. 2018; 6(10):747-758.
Bringing stability to the chronic obstructive pulmonary disease patient: clinical and pharmacological considerations for frequent exacerbators.
Gulati S, Wells JM. Drugs. 2017;77(6):651–670.
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.
Puhan MA, et al. Cochrane Database Syst Rev. 2016;12:CD005305.
Clinical Practice Tools and Resources
The COPD Foundation Pocket Consultant Guide Mobile App
The COPD Pocket Guide, provided by the COPD Foundation, contains comprehensive management information as well as resource tools. It can be downloaded on any mobile device.
Modified Medical Research Council (mMRC) Dyspnea Scale
The mMRC scale, provided by MDCalc, allows for the baseline stratification of dyspnea in COPD, as well as other respiratory diseases, and can be downloaded on any mobile device.
COPD Assessment Test (CAT)
The CAT, provided by the American Academy of Family Physicians, allows assessment of the global impact of COPD (cough, sputum, dyspnea, chest tightness) on patient health status.
COPD Action Plan
The COPD Action Plan, provided by the American Lung Association, is a tool that facilitates the prevention, timely identification, and early and appropriate treatment of COPD exacerbations.
HEDIS Measures and Technical Resources
The National Committee for Quality Assurance’s Healthcare Effectiveness Data and Information Set (HEDIS) is one of health care’s most widely used performance improvement tools.
Patient Resources and Advocacy Organizations
The COPD Foundation Pocket Consultant Guide, Patient-Focused Mobile App
The COPD Pocket Guide for Patients was designed to improve disease management and communication with a patient’s health care team. It includes patient resources such as inhaler and exercise videos as well as tools such as the wallet card and daily symptom tracker that help collect and share information with the health care team. It can be downloaded on any mobile device.
American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research.
COPD Foundation
The COPD Foundation’s mission is to prevent and cure COPD and to improve the lives of all people affected by COPD.
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
GOLD partners with health care professionals and public health officials to raise awareness of COPD and to improve prevention and treatment of this lung disease for patients around the world.
National Jewish Health
National Jewish Health integrates the latest scientific discoveries with coordinated care for lung, heart, and immune diseases. Their Patient Education Program provides many free educational opportunities and support groups to assist patients and caregivers with managing illnesses and chronic conditions, such as COPD.
Relevant Resources
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Improving Outcomes for Patients with COPD
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A New Era in Precision Medicine
Evolving Best Practices to Optimize Outcomes
Consensus and Controversies on the Road to Precision Medicine
Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care
Debates and Discussions About Personalizing Patient Management
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
From Guideline Recommendations to Daily Clinical Decision-Making
Improving Patient Outcomes Through Shared Clinical Decision Making
Improving Patient Outcomes Through Shared Clinical Decision Making
Digging Deep on Shared Decision-Making
Clinical Resource Center
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
Mechanistic Insights and Emerging Treatment Options
Best Practices for Primary Care
Evolving Best Practices for Patient Management
Shared Decision-making in the Era of Biologics
New Pathways to Patient Management
From Comprehensive Patient Evaluations to Individualized Evidence-based Care
Preventing COPD Exacerbations to Improve Outcomes
A Whole Patient Case Series
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
New Avenues to the Management of Severe Asthma
Evolving Best Practices for Pediatric Patients
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
Reducing LDL-C and a Lifetime of Cardiovascular Risk
A Multidisciplinary Look at Early Diagnosis and Management
Finding the Path in Chronic Rhinosinusitis with Nasal Polyps
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
Best Practices for Diagnosis and Management
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
New Pathways to Optimize Patient Outcomes
Debates and Discussions About New Upstream Treatment Avenues
A Case-Based Update on Pediatric Patients
Test Your Mastery!
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis
Practical Updates on the 2023 GOLD Guidelines
Incorporating New Data and Updated Guidelines Into Daily Practice